Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. NOVO
  4. NOVO — Februar 2026

NOVO — Februar 2026

Planlagt Fastgjort Låst Flyttet NOVO
875 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    pauly
    wrote on sidst redigeret af
    #865

    On the pen om lovgivning omkring compounding https://www.youtube.com/watch?v=y9TKVjmIrf8

    1 Reply Last reply
    0
    • P Offline
      P Offline
      ProinvestorNEWS
      wrote on sidst redigeret af
      #866

      I denne episode af The Downsized gennemgår Christopher Durham Novo Nordisks seneste REDEFINE 4-studieresultater for CagriSema - en næste generations fedmebehandling, der gav et gennemsnitligt vægttab på 23 % over 84 uger.

      Denne video udforsker, hvad resultaterne rent faktisk viste, hvorfor de er vigtige, og hvordan de afspejler et bredere skift i fedmebehandling. https://proinvestor.com/boards/131354/

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #867

        FDA approves Novo Nordisk's Sogroya® as the first and only once-weekly, long-acting growth hormone for three additional pediatric indicationsFDA approves Novo Nordisk's Sogroya® as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications https://www.novonordisk-us.com/media/news-archive/news-details.html?id=916507&utm_medium=organic&utm_source=twitter&utm_campaign=2026-media-release&utm_content=nni-pediatric-growth-sci_inn

        1 Reply Last reply
        0
        • CupcakeC Offline
          CupcakeC Offline
          Cupcake
          wrote on sidst redigeret af
          #868

          Data fra Wegovy Pill Trx viser: 36,1% af patienterne havde aldrig taget GLP-1-medicin før. 21,1% var skiftet fra en injicerbar version til Wegovy-pille, 15,8% var skiftet fra Eli Lillys injicerbare Zepbound.
          https://www.biospace.com/business/oral-wegovy-brings-in-thousands-of-new-glp-1-patients

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #869

            Lillys Orfoglipron 10. april? https://proinvestor.com/boards/131357

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Stroka
              wrote on sidst redigeret af
              #870

              Walgreens debuts virtual weight management clinic with access to GLP-1 meds https://www.fiercehealthcare.com/health-tech/walgreens-debuts-virtual-weight-management-clinic-access-glp-1-meds?_gl=1*1t145on*_gcl_au*MTE2MTI4NzAyLjE3NzE5NjE1NTM.*_ga*MTAzNTI1NzA2NC4xNzcxOTYxNTQz*_ga_KG49J84SR4*czE3NzIyNjE1MjYkbzckZzEkdDE3NzIyNjE1MzQkajUyJGwwJGgw

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bikube
                wrote on sidst redigeret af
                #871

                Seeking Alfa mener: Eli Lilly Vs Novo the valuation gap is unreasonable. Det kan jeg da kun give ham ret i.

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  pauly
                  wrote on sidst redigeret af
                  #872

                  Har du et link bikube?

                  1 Reply Last reply
                  0
                  • B Offline
                    B Offline
                    bikube
                    wrote on sidst redigeret af
                    #873

                    Nope - jeg snyder mig med gratis, jeg kan ikke en gang læse artiklen, kun overskriften.

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      pauly
                      wrote on sidst redigeret af
                      #874

                      okay

                      1 Reply Last reply
                      0
                      • CupcakeC Offline
                        CupcakeC Offline
                        Cupcake
                        wrote on sidst redigeret af
                        #875

                        Seeking Alfa artikel - l https://seekingalpha.com/article/4876511-eli-lilly-vs-novo-nordisk-the-valuation-gap-is-unreasonable

                        1 Reply Last reply
                        0
                        • CupcakeC Offline
                          CupcakeC Offline
                          Cupcake
                          wrote on sidst redigeret af
                          #876

                          (fort.) “Even with these rather conservative assumptions, Novo Nordisk seems to currently be undervalued by up to 60%.” Tror der er fri adgang til artiklen…

                          1 Reply Last reply
                          0

                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                          With your input, this post could be even better 💗

                          Tilmeld Log ind
                          Svar
                          • Svar som emne
                          Login for at svare
                          • Ældste til nyeste
                          • Nyeste til ældste
                          • Most Votes


                          • Log ind

                          • Har du ikke en konto? Tilmeld

                          • Login or register to search.
                          Powered by NodeBB Contributors
                          • First post
                            Last post
                          0
                          • Kategorier
                          • Seneste
                          • Etiketter
                          • Populære
                          • Verden
                          • Bruger
                          • Grupper